Analyzing Beyond Spotify’s Restructure: Unveiling 3 Stocks With Comparable Financial Challenges
Spotify restructured, reducing headcount by 17%, due to high cost structure impacting earnings. Benzinga found similar situations w/ 3 stocks.
Credit Card Juggernaut Mastercard’s Bold Financial Play: Dividend Hike & Massive Buyback
Yesterday, Mastercard Inc (NYSE: MA) disclosed a dividend increase and
JNJ CEO Signals No Rush Into Weight-Loss Drug Realm, Emphasizes Different Priorities
Johnson & Johnson (NYSE: JNJ) has no immediate plans to venture into weight-loss drugs due to the existing competition saturation, as Chief Executive Officer
Why Cigarette Company British American Tobacco Shares Are Diving Today
British American Tobacco PLC (NYSE: BTI) shares are trading lower by around 9% after it reported a
Obesity Drugs: Greater Weight Loss Linked to Prolonged Use of Novo Nordisk’s Wegovy
A recent analysis of medical records and insurance claims data revealed that 40% of patients who received prescriptions for Novo Nordisk A/S's (NYSE: NVO) obesity treatment drug Wegovy in 2021 or 2022 were still
2024’s Potential Stock Surprises: Goldman Sachs Unveils S&P 500 Laggards For Major Gains
Investors hunt for new opportunities in stocks that have been discounted & now present promising options for recovery.
Analyst Highlights Asset-Backed Cannabis Loans In Chicago Atlantic’s REFI With Overweight Rating
Zuanic & Associates (Z&A) recently initiated coverage of Chicago Atlantic Real Estate Finance Inc. (NASDAQ: REFI) with an Overweight rating. Chicago Atlantic is an externally managed commercial mortgage real estate investment trust.
Arvinas, Pfizer Plan To Broaden Development Of Breast Cancer Candidate
Arvinas Inc (NASDAQ: ARVN) and Pfizer Inc (NYSE: PFE) released clinical data for vepdegestrant (ARV-471) in combination with
Stocks Eye Rebound Following 2-Day Slump; Bitcoin, Ethereum Surge Past Trillion-Dollar Combined Market Value
Wall Street is poised for a rebound in Wednesday’s session, with futures on major U.S. indices in the green at 8:00 a.m. New York time, following two consecutive sessions of declines for the S&P 500.
Johnson & Johnson Settles Multiple Lawsuits Over Talc Cancer Claims, Eyes Prepackaged Bankruptcy
Johnson & Johnson's (NYSE: JNJ) worldwide vice president for litigation, Erik Haas, disclosed recent settlements with several law firms regarding claims linking J&J talc